A to Z
Data &
Forms &
News &
Licensing &
Rules &
Public Health
Communicable Disease Reporting Rules

Oregon Administrative Rules (OARs): Investigation and Control of Disease

All Oregon physicians, other health care providers, and laboratorians are required by law to report certain diseases and conditions to local health departments. Some cases are subject to restrictions on school attendance, day care attendance, patient care, and food handling. There are civil penalties (333-124-0001) for failure to comply with the statutory and administrative rule requirements in divisions 100 through 123. See also clinical laboratory regulations, and requirements for Oregon lab reporting to local health departments.

Proposed Rules

Notice of Proposed Rulemaking Hearing: New definitions and disease reporting requirements

To investigate the effect on humans of abnormally high levels of cadmium identified by the Oregon Department of Environmental Quality in some Portland neighborhoods, on February 18, 2016, we amended the Oregon Administrative Rules (OARs) on a temporary, emergency basis to require that any cadmium demonstrated by laboratory testing of urine be reported to public health officials (see Emergency Rule below). Guidelines for clinicians regarding sample collection and testing have been published and updated. Because this rule would otherwise expire after 180 days, (i.e., on August 18), the Oregon Health Authority (OHA) proposes a permanent rule along these lines.

Other changes are also proposed, including new definitions, deleting reporting of clinical pelvic inflammatory disease, and clarifying language around what makes an outbreak. For a summary of all the changes, refer to the June 14, 2016 CD Summary (pdf), which serves as official notice of these proposed rule changes.

For more details:
Public comment:
Public comment on these rules is now closed. Final rules will be filed after consideration of all comments.


Emergency Rule: Reporting Cadmium in Urine

​The Oregon Health Authority, Public Health Division is temporarily amending OAR 333-018-0015 pertaining to disease reporting. The amendment adds to the list of reportable diseases "cadmium demonstrated by laboratory testing of urine."

The rulemaking is effective February 18, 2016 - August 15, 2016. The Authority has proposed to make these rules permanent, (see Proposed Rules above).

Abnormally high levels of cadmium, a cumulative environmental pollutant and potential cause of chronic kidney disease, were recently identified by the Department of Environmental Quality in some Portland neighborhoods. This rule is needed to ascertain systematically reports of urine-positive cadmium results so that public health officials can investigate potential sources of intoxication, assess risk to the public and if necessary advise remedial actions.

For more details:

If you have any questions please call 211.
If you would prefer a hardcopy be sent, please send an email to

Current Rules

Communicable Disease Rules: Chapter 333, divisions 17, 18, 19, 26, 56  

DIVISION 17   Disease Control (definitions and references)

Changes: 1) Definitions of "Children's facility," "School" and "School Administrator" were added for the rule regarding exclusion of susceptibles in 333-019; 2) The threshold blood level for "Lead Poisoning" among children under 18 years of age was lowered from 10µg/dL to 5 µg/dL; 3) Changes were made to the definition of "Non-Susceptible to any Carbapenem Antibiotic."; and 4) Definitions of "Specimen Source Site" and "Specimen Type" were added for the new rule in 333-019.

  • 333-017-0000 --Definitions
  • 333-017-0005--Reference documents


DIVISION 18  Disease Reporting (responsibilities and requirements)

Changes: 1) Specimen source site and specimen type were added to the data required of laboratories reporting reportable diseases; 2) Amebic infection of the central nervous system and coccidioidomycosis are now reportable; 3) Submission of isolates of Coccioides spp. and novel influenza strains to the Oregon State Public Health Laboratories is now required; and 4)Although both entities remain reportable, submission of serum from patients with anti-hepatitis IgM or anti-HBc IgM is no longer required.

  • 333-018-0000--Who is responsible for reporting
  • 333-018-0005--To whom reports shall be made
  • 333-018-0010-- Form of the report
  • 333-018-0015-- What is to be reported and when
  • 333-018-0018-- Submission of isolates to the public health laboratory
  • 333-018-0020-- Handling of Reports by the local public health authorities
  • 333-018-0030-- Reporting of HIV test results
  • 333-018-0035-- Procedures involving emergency response employees [renumbered from 333-018-0023


DIVISION 19  Investigation and Control of Diseases (general powers and responsibilities)

Change: 1) Restrictable diseases were separated by facility (food service, schools, children's facilities, health care facilities) and 2)  the default requirement for exclusion of susceptibles in schools and children's facilities was limited to restrictable diseases that are also reportable diseases for which immunization is required under OAR 333-050-0050

  • 333-019-0000-- Responsibility of public health agencies to investigate reportable diseases
  • 333-019-0002-- Cooperation with public health authorities
  • 333-019-0005-- Conduct of special studies by the DHS; Disease-related school, child-care and worksite restrictions

Disease-Related School, Child Care, and Worksite Restrictions

  • 333-019-0010-- Imposition of restrictions
  • 333-019-0014-- Removal of restrictions

Pet licensing, animal bites and rabies

  • 333-019-0017-- Rabies vaccination for animals
  • 333-019-0019-- Dog licensing
  • 333-019-0022-- Wolf-dog hybrids
  • 333-019-0024-- Management of animal bites
  • 333-019-0027-- Management of possibly rabid animals

Other Disease-Specific Provisions

  • 333-019-0031--Acquired Immunodeficiency Syndrome / Human Immunodeficiency Virus [renumbered from 333-019-0223] (Note specific rules regarding reporting requirements for HIV and AIDS may be found in OAR 333-018-0015. Rules regarding informed consent for HIV testing and confidentiality of HIV test results may be fond in OAR 333-012-0265 and 333-012-0270.)
  • 333-019-0036--Special precautions relating to pregnancy and childbirth
  • 333-019-0039--Sudden Infant Death Syndrome [renumbered from 333-018-0025]
  • 333-019-0041--Tuberculosis [renumbered from 333-019-0405]
  • 333-019-0046--Typhoid


DIVISION 26 Enforcement of Public Health Rules

  • 33-026-0030--Civil Penalties for Violations of OAR Chapter 333, Divisions 18 and 19


DIVISION 56  Infectious Waste

Change:  The definition of "syringe" was restricted to those fitted with a hollow needle.

  • 333-056-0010--Purpose of infectious waste administrative rules
  • 333-056-0020--Definitions relating to infectious waste
  • 333-056-0030--Infectious waste treatment
  • 333-056-0040--Infectious waste storage times and temperatures
  • 333-056-0050--Prevention of disease transmission by blood-contaminated sharp objects
Related Oregon Health Authority Rules

Oregon Department of Education (ODE)

Return to top